Literature DB >> 36249639

A Review on Glaucoma Drainage Devices and its Complications.

Sajal Gupta1, Sandhya Jeria1.   

Abstract

Glaucoma is one of the leading causes of blindness in the world. It is an ocular disorder that may have multiple etiologies and which can present as optic neuropathy and increased intraocular pressure (IOP), but in some cases like normotensive glaucoma, the IOP may remain normal. Its gradually progressive nature makes it important for early diagnosis; although the loss of vision is slow, lost vision can't be restored. Glaucoma drainage implant surgeries are an increasingly popular option in recent days in complicated cases of glaucoma where the previous trabeculectomy had failed and medical management was not responsive. Glaucoma drainage devices (GDD) are of various designs; they are implanted according to the patient condition and surgeons' preference. There are complications after the implantation of a GDD like hypotony, endophthalmitis, migration of the plate, extrusion, erosion of the mucous membrane, etc. In the market, there are various drainage devices present, but some of them are frequently used and popular. In this article, we will discuss some most commonly used GDDs and their complications. Among these, four are the most popular: Molteno, Baerveldt, Krupin, and Ahmed. The failure rate of the GDD is low. In many studies, it has been noted that only half of the GDD remains functional after five years. Therefore, further studies are still being conducted to refine the biomaterials, techniques, and shape of the GDD. The technique of surgery is also very much crucial in the success of GDD implantation. The glaucoma type is an essential factor in deciding the treatment, and the outcome of the surgery also depends on it.
Copyright © 2022, Gupta et al.

Entities:  

Keywords:  ahmed; baerveldt; g.d.d; glaucoma; i.o.p; krupin; molteno

Year:  2022        PMID: 36249639      PMCID: PMC9554953          DOI: 10.7759/cureus.29072

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  31 in total

1.  Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma.

Authors:  Elizenda M Ceballos; Richard K Parrish; Joyce C Schiffman
Journal:  Ophthalmology       Date:  2002-12       Impact factor: 12.079

Review 2.  Preventing and treating complications of Baerveldt Glaucoma Drainage Device surgery.

Authors:  Herbert P Fechter; Richard K Parrish
Journal:  Int Ophthalmol Clin       Date:  2004

Review 3.  Patch graft materials for glaucoma tube implants.

Authors:  John T Lind; Thomas S Shute; Arsham Sheybani
Journal:  Curr Opin Ophthalmol       Date:  2017-03       Impact factor: 3.761

4.  Krupin eye valve with disk for filtration surgery. The Krupin Eye Valve Filtering Surgery Study Group.

Authors: 
Journal:  Ophthalmology       Date:  1994-04       Impact factor: 12.079

Review 5.  Glaucoma treatment trends: a review.

Authors:  Ronan Conlon; Hady Saheb; Iqbal Ike K Ahmed
Journal:  Can J Ophthalmol       Date:  2016-11-17       Impact factor: 1.882

6.  Aurolab Aqueous Drainage Implant (AADI): Review of Indications, Mechanism, Surgical Technique, Outcomes, Impact and Limitations.

Authors:  Vishwendra Pratap Singh Sisodia; Rashmi Krishnamurthy
Journal:  Semin Ophthalmol       Date:  2022-06-03       Impact factor: 1.975

Review 7.  The Baerveldt Glaucoma Drainage Device: Efficacy, Safety, and Place in Therapy.

Authors:  Huub J Poelman; Roger C W Wolfs; Wishal D Ramdas
Journal:  Clin Ophthalmol       Date:  2020-09-24

Review 8.  The medical and surgical treatment of glaucoma.

Authors:  Thomas S Dietlein; Manuel M Hermann; Jens F Jordan
Journal:  Dtsch Arztebl Int       Date:  2009-09-11       Impact factor: 5.594

Review 9.  Glaucoma drainage implants: a critical comparison of types.

Authors:  Kenneth S Schwartz; Richard K Lee; Steven J Gedde
Journal:  Curr Opin Ophthalmol       Date:  2006-04       Impact factor: 3.761

Review 10.  The pathophysiology and treatment of glaucoma: a review.

Authors:  Robert N Weinreb; Tin Aung; Felipe A Medeiros
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.